184 related articles for article (PubMed ID: 21217131)
1. Atrial fibrillation and renin-angiotensin-aldosterone system: believe it or not.
Fauchier L; de Groote P
Europace; 2011 Mar; 13(3):297-8. PubMed ID: 21217131
[No Abstract] [Full Text] [Related]
2. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and atrial fibrillation: a meta-analysis.
Liu T; Korantzopoulos P; Xu G; Shehata M; Li D; Wang X; Li G
Europace; 2011 Mar; 13(3):346-54. PubMed ID: 21076147
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation.
Levine MJ; Schweitzer P
Vnitr Lek; 2010 Nov; 56(11):1138-41. PubMed ID: 21247007
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
Zografos T; Katritsis DG
Pacing Clin Electrophysiol; 2010 Oct; 33(10):1270-85. PubMed ID: 20636314
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
Heusch G; Schulz R
Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
[TBL] [Abstract][Full Text] [Related]
6. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
Dabrowski R; Szwed H
Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
[No Abstract] [Full Text] [Related]
7. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population.
Ravn LS; Benn M; Nordestgaard BG; Sethi AA; Agerholm-Larsen B; Jensen GB; Tybjaerg-Hansen A
Pharmacogenet Genomics; 2008 Jun; 18(6):525-33. PubMed ID: 18496132
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.
Khatib R; Joseph P; Briel M; Yusuf S; Healey J
Int J Cardiol; 2013 Apr; 165(1):17-24. PubMed ID: 22421406
[TBL] [Abstract][Full Text] [Related]
9. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
Ducharme A; Schiffrin EL
Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of inhibitory renin-angiotensin system as a genetic risk factor for atrial fibrillation.
Ogimoto A; Higaki J; Miki T
Circulation; 2004 Sep; 110(13):e329; author reply e329. PubMed ID: 15451813
[No Abstract] [Full Text] [Related]
11. The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target?
Freestone B; Beevers DG; Lip GY
J Hum Hypertens; 2004 Jul; 18(7):461-5. PubMed ID: 14973520
[No Abstract] [Full Text] [Related]
12. Atrial remodeling in persistent atrial fibrillation: the potential role of aldosterone.
Korantzopoulos P; Kolettis T; Kountouris E; Siogas K
Eur Heart J; 2004 Jun; 25(12):1086; author reply 1086-7. PubMed ID: 15191783
[No Abstract] [Full Text] [Related]
13. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.
Tayebjee MH; Creta A; Moder S; Hunter RJ; Earley MJ; Dhinoja MB; Schilling RJ
Europace; 2010 Nov; 12(11):1537-42. PubMed ID: 20682557
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials, the renin angiotensin system and atrial fibrillation.
Birnie DH; Gollob M; Healey JS
Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
[TBL] [Abstract][Full Text] [Related]
15. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
Healey JS; Morillo CA; Connolly SJ
Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme insertion/deletion gene polymorphisms associated with risk of atrial fibrillation: A meta-analysis of 23 case-control studies.
Ma R; Li X; Su G; Hong Y; Wu X; Wang J; Zhao Z; Song Y; Ma S
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):793-800. PubMed ID: 26041129
[TBL] [Abstract][Full Text] [Related]
17. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: who is a responder?
Berkowitsch A; Neumann T; Kuniss M; Janin S; Wojcik M; Zaltsberg S; Mitrovic V; Pitschner HF
Pacing Clin Electrophysiol; 2010 Sep; 33(9):1101-11. PubMed ID: 20487340
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation and renin-angiotensin system.
Serra JL; Bendersky M
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
[TBL] [Abstract][Full Text] [Related]
19. Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
Boos CJ; Lip GY
J Hum Hypertens; 2005 Nov; 19(11):855-9. PubMed ID: 16094406
[No Abstract] [Full Text] [Related]
20. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
Doğan A; Akçay S
Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
